Get the Stockscreener App
100.62
1.41%
1.40
After Hours:
100.31
-0.31
-0.31%
Spdr Biotech Etf stock is traded at $100.62, with a volume of 7.12M.
It is up +1.41% in the last 24 hours and up +3.19% over the past month.
See More
Previous Close:
$99.22
Open:
$98.71
24h Volume:
7.12M
Relative Volume:
1.04
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.09%
1M Performance:
+3.19%
6M Performance:
+11.82%
1Y Performance:
+40.81%
1-Day Range:
$98.20
$100.63
1-Week Range:
$96.84
$100.63
52-Week Range:
$64.99
$103.52
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Spdr Biotech Etf Stock (XBI) Latest News
(XBI) Investment Analysis and Advice - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Best Biotech ETFs to Watch Right Now - The Motley Fool
XBI: Biotech ETF Is A Must Have (NYSEARCA:XBI) - Seeking Alpha
(XBI) Technical Pivots with Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
Biotech and Retail ETFs have the highest implied call return, according to Goldman - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
8 Charts Suggesting Stock Market Pullback Could Deepen in the Near-Term - Investing.com
How To Trade (XBI) - Stock Traders Daily
7 Best-Performing Biotech ETFs for October 2024 - NerdWallet
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
SPDR Bloomberg Short Term High Yield Bond ETF (NYSEARCA:SJNK) Reaches New 1-Year High at $25.74 - Defense World
Biotech IPOs return as sector recovers after funding overhang - Seeking Alpha
Where are the Opportunities in (XBI) - Stock Traders Daily
(09/26/24) BCYC: A Promising Play in the Biotech Sector - Moneyshow.com
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MSN
XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis) - Seeking Alpha
Objective long/short (XBI) Report - Stock Traders Daily
Why Biotech ETFs Are Beating the Market - TradingView
Biotech Stocks Look Ready to Rally - Barron's
Biotech stocks poised for a comeback as interest rates fall - ShareCafe
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue. - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
3 Biotech ETFs for a Diversified Portfolio - Inkl
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
2 Biotech Stocks to Buy Hand Over Fist in August - MSN
Mather Group LLC. Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
(XBI) Trading Report - Stock Traders Daily
2 Biotech Stocks Making Moves Today - Schaeffers Research
Form 424B2 BofA Finance LLC - StreetInsider.com
3 Biotech Names With Potential Catalysts By Year End - Seeking Alpha
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. - sharewise
Osaic Holdings Inc. Acquires 179 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech ETF (XBI) rallied from the blue box hitting target - FXStreet
Biotech ETF (XBI) Rallied From The Blue Box Hitting Target - Barchart
TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target - Barchart
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
Kingsview Wealth Management LLC Purchases 127 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Banco Santander S.A. - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Avantax Advisory Services Inc. - Defense World
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):